Angiomyolipoma has emerging NIH research funding with 1 grant totaling $1.2M.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Angiomyolipoma. Strongest funded area: Translational / Drug Development. Largest gap: Epidemiology / Natural History.
15 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for angiomyolipoma. Existing research activity suggests this may be a viable area for grant applications.
24 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for angiomyolipoma. Existing research activity suggests this may be a viable area for grant applications.
12 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for angiomyolipoma. Existing research activity suggests this may be a viable area for grant applications.
10 publications in Basic Science / Preclinical but no NIH-funded grants found in Basic Science for angiomyolipoma. Existing research activity suggests this may be a viable area for grant applications.
13 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for angiomyolipoma. Existing research activity suggests this may be a viable area for grant applications.
These grants mention Angiomyolipoma as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Track funding opportunities for Angiomyolipoma.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.